Bicara Therapeutics (BCAX) vs MannKind (MNKD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Bicara Therapeutics (BCAX) has outperformed MannKind (MNKD) over the past year, losing 9.6% versus a loss of 38.9%. MannKind is the larger company by market cap ($1.11 billion vs $1.09 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCAX | MNKD |
|---|---|---|
| Share price | $16.42 | $3.45 |
| Market cap | $1.09B | $1.11B |
| 1-day change | -0.85% | -7.01% |
| YTD return | -2.44% | -39.15% |
| 1-year return | -9.63% | -38.94% |
| 5-year return | — | -32.22% |
| Forward P/E | — | 27.06 |
| EPS (TTM) | $-3.08 | $-0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.99 | $6.51 |
| 52-week low | $13.70 | $2.23 |
| Distance from 52-week high | -47.02% | -47.00% |
| Average volume | 609.70K | 4.50M |
| Shares outstanding | 66.17M | 321.54M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BCAX has outperformed MNKD by 29.3 percentage points over the past year.
BCAX vs MNKD FAQ
Which is bigger, Bicara Therapeutics or MannKind?
MannKind (MNKD) is larger, with a market capitalization of $1.11B compared with $1.09B for Bicara Therapeutics (BCAX).
Which stock has performed better over the past year, BCAX or MNKD?
BCAX returned -9.63% over the past 12 months, compared with -38.94% for MNKD (price return, excluding dividends). Past performance does not predict future results.
Are Bicara Therapeutics and MannKind in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.